CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer

BACKGROUND: Although radical surgery remains the cornerstone of cure in resectable gastric cancer, survival remains poor. Current evidence-based (neo)adjuvant strategies have shown to improve outcome, including perioperative chemotherapy, postoperative chemoradiotherapy and postoperative chemotherap...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Slagter, Astrid E., Jansen, Edwin P. M., van Laarhoven, Hanneke W. M., van Sandick, Johanna W., van Grieken, Nicole C. T., Sikorska, Karolina, Cats, Annemieke, Muller-Timmermans, Pietje, Hulshof, Maarten C. C. M., Boot, Henk, Los, Maartje, Beerepoot, Laurens V., Peters, Frank P. J., Hospers, Geke A. P., van Etten, Boudewijn, Hartgrink, Henk H., van Berge Henegouwen, Mark I., Nieuwenhuijzen, Grard A. P., van Hillegersberg, Richard, van der Peet, Donald L., Grabsch, Heike I., Verheij, Marcel
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Study Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6131797/
https://ncbi.nlm.nih.gov/pubmed/30200910
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4770-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados